Tenaya Therapeutics, Inc.
TNYA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001858848
In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Tenaya Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +21 vs. Q4 2024
- Shares held
- 48.6M
- +4.99M (+11.4%) vs. Q4 2024
- Total value
- $27.7M
- −$34.6M (−55.6%) vs. Q4 2024
- New holders
- 31
- 22 more added
- Sold out
- 10
- 32 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $39.7M |
| Q1 2026 | 103 | $37.5M |
| Q4 2025 | 98 | $48.8M |
| Q3 2025 | 91 | $55.6M |
| Q2 2025 | 89 | $19.3M |
| Q1 2025 | 107 | $27.7M |
| Q4 2024 | 88 | $62.8M |
| Q3 2024 | 95 | $111.2M |
| Q2 2024 | 96 | $177.0M |
| Q1 2024 | 90 | $292.9M |
| Q4 2023 | 74 | $151.4M |
| Q3 2023 | 77 | $126.8M |
| Q2 2023 | 79 | $279.7M |
| Q1 2023 | 65 | $128.3M |
| Q4 2022 | 68 | $94.7M |
| Q3 2022 | 73 | $102.2M |
| Q2 2022 | 50 | $208.6M |
| Q1 2022 | 50 | $439.9M |
| Q4 2021 | 47 | $667.6M |
| Q3 2021 | 47 | $693.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Tenaya Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 1,555,556 | $886.8K | 0.08% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,258,512 | $1.29M | 0.00% | −2,897,084−56.2% | Reduced |
| Vanguard Group Inc | 4,082,032 | $2.33M | 0.00% | +809,988+24.8% | Added |
| BlackRock, Inc. | 5,256,602 | $3.00M | 0.00% | −39,874−0.8% | Reduced |
| Woodline Partners LP | 5,916,167 | $3.37M | 0.02% | +5,896,873+30,563.2% | Added |
| Casdin Capital, LLC | 6,732,971 | $3.84M | 0.31% | 00.0% | Unchanged |
| The Column Group LLC | 9,400,290 | $5.36M | 12.12% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −438,886−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −126,008−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −56,996−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −31,141−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −22,262−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,687−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −18,259−100.0% | Sold out |
| Accredited Investor Services, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| AlphaMark Advisors, LLC | – | – | – | – | Not filed |